4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-21-012124
SVP & General Counsel sold 2,173 shares at $22.37 ($48,610)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wilson Mark Andrew SVP & General Counsel | 2021-02-16 | Sale | −2,173 | $22.37 | $48,610 | 76,727 | D: show line 1 in the form |
| Open-market sales · 2,173 sh · avg $22.37 · $48,610 | |||||||
Loading xslF345X03/doc4.xml…